Sarah W. Ball, MPH, ScD

Westat

Disclosure(s): Centers for Disease Control and Prevention, Contract #200-2019-F-06819: Grant/Research Support; Centers for Disease Control and Prevention, Contract #75D30121D12779: Grant/Research Support; Novavax: Grant/Research Support

Poster(s):

• (P-1435) Effectiveness of RSV Immunization among Infants in Their First RSV Season in the United States, 2023-2024 and 2024-2025 Seasons
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET

• (P-1501) Effectiveness of 2024–2025 seasonal influenza vaccines against influenza–associated hospitalizations among adults — VISION Network
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET

• (P-1517) Adult Respiratory Syncytial Virus Vaccination Receipt among Adults Testing Negative for RSV – VISION Network, October 1, 2024—March 31, 2025
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET

• (P-1657) Difference in reactogenicity events between mRNA and Protein-subunit Vaccines: Results from the Booster Epidemiological Evaluation of Health, Illness, and Vaccine Efficacy (BEEHIVE) Study, a U.S. randomized trial of 2023-2024 COVID-19 vaccines (XBB.1.5)
  Wednesday, October 22, 2025

  12:15 PM - 1:30 PM US ET

• (P-1982) Negative Predictive Value of Methods to Identify Underlying Medical Conditions with and without Use of a Lookback Period among Adults with a Healthcare Encounter for Acute Respiratory Illness, September 2023 – August 2024
  Wednesday, October 22, 2025

  12:15 PM - 1:30 PM US ET